Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : Mangoceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Mangoceuticals Reports H1N1 Viral Load Reduction, Expands to H5N1 Research
Details : Company is evaluating a patented respiratory illness prevention technology against the H5N1 virus (Avian Influenza) infection.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 06, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : Mangoceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
